Al-Ola A Abdallah MD (USMIRC)

Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Dr. Makhoul has always been very instrumental in my career. I really appreciate your mentorship and guidance. Thank you so much. I have learned a lot from you during my fellowship

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

My reaction every time I hear someone attack @USMIRCNEWS…

“A disappointing voice in a field that deserves better.”

[CancerNetwork® @CancerNetwrk]

📹May’s ONCOLOGY Monthly Spotlight is on its way (just a tad late)! @YLeyfman breaks down why CAR-T is transforming expectations in multiple myeloma.

📖 Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma

https://t.co/ORg2aegQ6T

Read the latest from ONCOLOGY and join the discussion!

#mmsm #hematology #oncology | @Abdallah81MD

[OncoDaily @oncodaily]

The Best of the Best Will Be Leading the National ICE-T Congress in Orlando - Al-Ola Abdallah

@Abdallah81MD

https://t.co/Ap2T7yln7Q

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🧵 Post-BCMA Failure in RRMM: What should we do next? 🤔

A new multicenter USMIRC/US academic center real-world analysis provides practical insights into sequencing after BCMA-directed therapy failure. Here are the key takeaways for clinicians 👇

1️⃣ BCMA-directed therapy failure is becoming increasingly common, yet the optimal sequencing strategy remains undefined.

📌 This analysis integrates 3 multicenter real-world cohorts evaluating:
🔹 BCMA CAR-T
🔹 BCMA bispecific antibodies
🔹 Talquetamab (GPRC5D)

#mmsm #myeloma #MedEd #Medtwitter #USMIRC @oncodaily @USMIRCNEWS @US_HMC @CurrentOncology @MedwatchKate @Larvol #المايلوما #سرطان_الدم

[USMIRC News @USMIRCNEWS]

USMIRC Newsletter 6/2026 #mmsm #myeloma

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Evaluation of Real-World Studies on Management of Relapsed Multiple Myeloma After BCMA-Directed Therapy Failure from U.S. Academic Centers and USMIRC
#mmsm #myeloma #MedEd #medtwitter #USMIRC @MedwatchKate @USMIRCNEWS @US_HMC @Larvol @oncodaily
https://t.co/GqBxjeIJKS

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🧵 Post-BCMA Failure in RRMM: What should we do next? 🤔

A new multicenter USMIRC/US academic center real-world analysis provides practical insights into sequencing after BCMA-directed therapy failure. Here are the key takeaways for clinicians 👇

1️⃣ BCMA-directed therapy failure is becoming increasingly common, yet the optimal sequencing strategy remains undefined.

📌 This analysis integrates 3 multicenter real-world cohorts evaluating:
🔹 BCMA CAR-T
🔹 BCMA bispecific antibodies
🔹 Talquetamab (GPRC5D)

#mmsm #myeloma #MedEd #Medtwitter #USMIRC @oncodaily @USMIRCNEWS @US_HMC @CurrentOncology @MedwatchKate @Larvol #المايلوما #سرطان_الدم

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Goaaaaaal Jordan 🇯🇴

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Game will start now #Algérie #argentina #worldcup2026 #كاس_العالم_٢٠٢٦

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Today we are all with a Algeria 🇩🇿 in Kansas City 🙌
#Algérie #الجزائر_الأرجنتين

[#AllegriOut 🇵🇸 @AFanghor_35]

كانساس سيتي شعلت 😂🔥

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Thank you
شكراً
Merci
Gracias
Teşekkür ederim
谢谢
ありがとうございます

[Current Oncology @CurrentOncology]

🚀 Welcome to read the new #article published in the Special Issue "U.S. Myeloma Innovations Research Collaborative (USMIRC) Collection."
📍 https://t.co/3PhLPjOA0r

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

@CurrentOncology Thank you
شكراً
Merci
Gracias
Teşekkür ederim
谢谢
ありがとうございます

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

كأس العالم ليس للذوي القلوب الضعيفة😅

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🚨 if you are watching the #FIFAWorldCup you might be at risk for Cardiovascular events! ⚽

In the 2006 World Cup:
🫀 Cardiac emergencies ↑2.7×
💥 STEMI ↑2.5×
⚡ Arrhythmias ↑3×

For patients with coronary artery disease, the biggest opponent may not be the team on the field—but the stress in the stands.
#Medtwitter

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🚨🔥 BIG NEWS | #ICETCongress 2026 🔥🚨

Get ready, Orlando! 🌴

📍 Orlando, FL
🗓 July 18, 2026

https://t.co/5cNbGGsGDP

The National ICE-T Congress is back—bigger, bolder, and pushing the future of #CellTherapy forward 🚀
#mmsm #MedEd #medtwitter #USMIRC @Larvol @USMIRCNEWS @MedwatchKate @US_HMC

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🚨🔥 BIG NEWS | #ICETCongress 2026 🔥🚨

Get ready, Orlando! 🌴

📍 Orlando, FL
🗓 July 18, 2026

The National ICE-T Congress is back—bigger, bolder, and pushing the future of #CellTherapy forward 🚀

⭐ Led by powerhouse chairs: @heMEGirl_MD @HemSandoval
and our ICE-T Executive Director: @kczmj

⚡ CAR-T
⚡ Bispecifics
⚡ Real-world innovation
⚡ Multidisciplinary impact

This is where the future of hematology meets action. Don’t miss it.
@NausheenAhmedMD @KUcancercenter @USMIRCNEWS @oncodaily @MedwatchKate @US_HMC #MedEd #medtwitter

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Infographic summary:

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🧵 Post-BCMA Failure in RRMM: What should we do next? 🤔

A new multicenter USMIRC/US academic center real-world analysis provides practical insights into sequencing after BCMA-directed therapy failure. Here are the key takeaways for clinicians 👇

1️⃣ BCMA-directed therapy failure is becoming increasingly common, yet the optimal sequencing strategy remains undefined.

📌 This analysis integrates 3 multicenter real-world cohorts evaluating:
🔹 BCMA CAR-T
🔹 BCMA bispecific antibodies
🔹 Talquetamab (GPRC5D)

#mmsm #myeloma #MedEd #Medtwitter #USMIRC @oncodaily @USMIRCNEWS @US_HMC @CurrentOncology @MedwatchKate @Larvol #المايلوما #سرطان_الدم

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

8️⃣ 💬 Bottom line

The future of myeloma is no longer just about choosing the next therapy—it’s about choosing the right sequence.

🧩 As BCMA-directed therapies move earlier in treatment, optimizing post-BCMA sequencing may become one of the most important questions in RRMM.

#mmsm #MultipleMyeloma #CAR_T #Bispecifics #Hematology #Oncology
#mmsm #myeloma #MedEd #Medtwitter #USMIRC @oncodaily @USMIRCNEWS @US_HMC @CurrentOncology @MedwatchKate @Larvol #المايلوما #سرطان_الدم

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

https://t.co/X8O7FTfhVR

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

Dutcher bodies in MM: intracytoplasmic immunoglobulin inclusions that invaginate into or overlie the nucleus, mostly associated with t(4;14) #mmsm #MYELOMA #MedTwitter #MedEd #USMIRC @USMIRCNEWS @US_HMC

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

🚨 if you are watching the #FIFAWorldCup you might be at risk for Cardiovascular events! ⚽

In the 2006 World Cup:
🫀 Cardiac emergencies ↑2.7×
💥 STEMI ↑2.5×
⚡ Arrhythmias ↑3×

For patients with coronary artery disease, the biggest opponent may not be the team on the field—but the stress in the stands.
#Medtwitter

[Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD]

https://t.co/GqBxjeIJKS
#MedEd #medtwitter #WorldCup #USMIRC #mmsm #myeloma